Cargando…

Status of potential PfATP6 molecular markers for artemisinin resistance in Suriname

BACKGROUND: Polymorphisms within the PfATP6 gene have been indicated as potential molecular markers for artemisinin efficacy. Since 2004, the use of artemisinin combination therapy (ACT) was introduced as first-line treatment of the uncomplicated malaria cases in Suriname. The aim of this research w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adhin, Malti R, Labadie-Bracho, Mergiory, Vreden, Stephen G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468384/ https://www.ncbi.nlm.nih.gov/pubmed/22966810 http://dx.doi.org/10.1186/1475-2875-11-322

Ejemplares similares

Gold mining areas in Suriname: reservoirs of malaria resistance?
por: Adhin, Malti R, et al.
Publicado: (2014)

Trends of influenza infection in Suriname
por: Adhin, Malti R., et al.
Publicado: (2012)

Malaria serology data from the Guiana shield: first insight in IgG antibody responses to Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae antigens in Suriname
por: Labadie-Bracho, Mergiory Y., et al.
Publicado: (2020)

Advocating for PCR-RFLP as molecular tool within malaria programs in low endemic areas and low resource settings
por: Labadie-Bracho, Mergiory Y., et al.
Publicado: (2023)

Mechanism of artemisinin resistance for malaria PfATP6 L263 mutations and discovering potential antimalarials: An integrated computational approach
por: N., Nagasundaram, et al.
Publicado: (2016)

Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname
por: Vreden, Stephen GS, et al.
Publicado: (2016)

Evidence of an increased incidence of day 3 parasitaemia in Suriname: an indicator of the emerging resistance of Plasmodium falciparum to artemether
por: Vreden, Stephen GS, et al.
Publicado: (2013)

Questions over high frequency of mutant PfATP6 haplotypes in traveller isolates
por: Woodrow, Charles J, et al.
Publicado: (2012)

Purified E255L Mutant SERCA1a and Purified PfATP6 Are Sensitive to SERCA-type Inhibitors but Insensitive to Artemisinins
por: Cardi, Delphine, et al.
Publicado: (2010)

Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
por: Ashton, Trent D., et al.
Publicado: (2023)

Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname
por: Mac Donald-Ottevanger, M Sigrid, et al.
Publicado: (2017)

Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections
por: Pillai, Dylan R, et al.
Publicado: (2012)

Epidemiology of respiratory viruses in patients with severe acute respiratory infections and influenza‐like illness in Suriname
por: Grunberg, Meritha, et al.
Publicado: (2020)

Metabolic responses in blood-stage malaria parasites associated with increased and decreased sensitivity to PfATP4 inhibitors
por: Tewari, Shivendra G., et al.
Publicado: (2023)

First Chikungunya Outbreak in Suriname; Clinical and Epidemiological Features
por: van Genderen, Farah T., et al.
Publicado: (2016)

Na(+) Regulation in the Malaria Parasite Plasmodiumfalciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone Antimalarials
por: Spillman, Natalie J., et al.
Publicado: (2013)

The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs
por: Spillman, Natalie Jane, et al.
Publicado: (2015)

Mutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone Antimalarials
por: Flannery, Erika L., et al.
Publicado: (2014)

A 4-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4
por: Gilson, Paul R., et al.
Publicado: (2019)

A G358S mutation in the Plasmodium falciparum Na(+) pump PfATP4 confers clinically-relevant resistance to cipargamin
por: Qiu, Deyun, et al.
Publicado: (2022)

PfATP4 inhibitors in the Medicines for Malaria Venture Malaria Box and Pathogen Box block the schizont-to-ring transition by inhibiting egress rather than invasion
por: Barnes, Claudia B. G., et al.
Publicado: (2022)

Quality of anti-malarials collected in the private and informal sectors in Guyana and Suriname
por: Evans, Lawrence, et al.
Publicado: (2012)

Pfatp6 molecular profile of Plasmodium falciparum isolates in the western Brazilian Amazon
por: Brasil, Larissa W, et al.
Publicado: (2012)

Structure-based drug design studies of the interactions of ent-kaurane diterpenes derived from Wedelia paludosa with the Plasmodium falciparum sarco/endoplasmic reticulum Ca(2+)-ATPase PfATP6
por: Guimarães, Daniel Silqueira Martins, et al.
Publicado: (2015)

History of malaria research and its contribution to the malaria control success in Suriname: a review
por: Breeveld, Florence JV, et al.
Publicado: (2012)

Three atypical lethal cases associated with acute Zika virus infection in Suriname
por: Zonneveld, Rens, et al.
Publicado: (2016)

Were medicine quality and pharmaceutical management contributing factors in diminishing artemisinin efficacy in Guyana and Suriname?
por: Pribluda, Victor S, et al.
Publicado: (2014)

Zika Virus Seroprevalence in Urban and Rural Areas of Suriname, 2017
por: Langerak, Thomas, et al.
Publicado: (2019)

Variation in Plasmodium falciparum Histidine-Rich Protein 2 (Pfhrp2) and Plasmodium falciparum Histidine-Rich Protein 3 (Pfhrp3) Gene Deletions in Guyana and Suriname
por: Akinyi Okoth, Sheila, et al.
Publicado: (2015)

PfCRT and PfMDR1 modulate interactions of artemisinin derivatives and ion channel blockers
por: Eastman, Richard T., et al.
Publicado: (2016)

Fifty years of primary health care in the rainforest: temporal trends in morbidity and mortality in indigenous Amerindian populations of Suriname
por: Eersel, Marthelise GM, et al.
Publicado: (2018)

Prediction of virological failure in HIV-infected individuals treated with cART in Suriname
por: Bleijenberg, MP, et al.
Publicado: (2010)

Genetic background and PfKelch13 affect artemisinin susceptibility of PfCoronin mutants in Plasmodium falciparum
por: Sharma, Aabha I., et al.
Publicado: (2020)

Surinam : neues lebenaufalter erde /

Severity of acute Zika virus infection: A prospective emergency room surveillance study during the 2015–2016 outbreak in Suriname
por: Vroon, Pieter, et al.
Publicado: (2017)

Ethnic differences in hepatitis A and E virus seroprevalence in patients attending the Emergency Department, Paramaribo, Suriname
por: Mac Donald-Ottevanger, M S, et al.
Publicado: (2022)

Ethnic disparities in tuberculosis incidence and related factors among indigenous and other communities in ethnically diverse Suriname
por: Gopie, F.A., et al.
Publicado: (2021)

Sexually transmitted infections on the border between Suriname and French Guiana: A scoping review
por: Nacher, Mathieu, et al.
Publicado: (2022)

Zika Virus Infection and Guillain–Barré Syndrome in Three Patients from Suriname
por: Langerak, Thomas, et al.
Publicado: (2016)

Yellow fever in a traveller returning from Suriname to the Netherlands, March 2017
por: Wouthuyzen-Bakker, Marjan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_upptbrr8pd5clpv8hacbtovds1